Login / Signup

Autoantibodies, cutaneous subset and immunosuppressants contribute to the cancer risk in systemic sclerosis.

Antonio TonuttiFrancesca MottaNatasa IsailovicAngela CeribelliRita RagusaEmanuele NappiStefanos BonovasCarlo Francesco SelmiMaria De Santis
Published in: RMD open (2024)
Cancer surveillance should be particularly careful in patients with diffuse SSc, increased age at disease onset and without classical SSc-related autoantibodies.
Keyphrases
  • systemic sclerosis
  • interstitial lung disease
  • systemic lupus erythematosus
  • papillary thyroid
  • public health
  • squamous cell
  • low grade
  • rheumatoid arthritis
  • squamous cell carcinoma
  • young adults
  • high grade
  • drug induced